COMMONWEALTH EQUITY SERVICES, LLC

Position in ZYME — Zymeworks Inc.

CIK 312272 WALTHAM, MA

Position in ZYME

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$837,839

+$186,023 QoQ

Shares Held

32,052

+23.1% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#96

of 203 holders

Holding Since

Dec 2022

15 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. ZYME ranks #28 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$837,839	32,052	+23.1%	Shares	Sole	2026-07-29
2026-03-31	$651,816	26,031	-0.2%	Shares	Sole	2026-04-27
2025-12-31	$687,081	26,095	-16.5%	Shares	Sole	2026-02-12
2025-09-30	$533,527	31,237	-2.9%	Shares	Sole	2025-10-22
2025-06-30	$403,733	32,170	-14.5%	Shares	Sole	2025-08-06
2025-03-31	$448,316	37,642	+21.6%	Shares	Sole	2025-05-09
2024-12-31	$453,254	30,960	+16.1%	Shares	Sole	2025-02-10
2024-09-30	$334,658	26,666	-5.3%	Shares	Sole	2024-10-18
2024-06-30	$239,692	28,166	-17.6%	Shares	Sole	2024-07-31
2024-03-31	$359,426	34,166	+33.1%	Shares	Sole	2024-04-29
2023-12-31	$266,669	25,666	0.0%	Shares	Sole	2024-02-06
2023-09-30	$162,722	25,666	-0.3%	Shares	Sole	2023-10-23
2023-06-30	$222,428	25,744	-1.2%	Shares	Sole	2023-08-10
2023-03-31	$235,437	26,044	+1.2%	Shares	Sole	2023-05-11
2022-12-31	$202,347	25,744	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.